2019 annual financial data

BioRestorative Therapies 2019 Net margin

Direct answer

Net margin was -11,267.61%.

Operating income was -8,432,005 USD and net income was -14,647,890 USD.
Operating cash flow was -6,918,734 USD.

Get free BioRestorative Therapies email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
130,000 USD
Operating income
-8,432,005 USD
Net income
-14,647,890 USD
Operating cash flow
-6,918,734 USD